CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 1 - 10 of 730
Study Number Lead Group Study Title CIRB Study Status
S1400ANCILLARY SWOG Ancillary Study to Evaluate Patient and Physician Attitudes; Knowledge; and Expectations Related to Return of Genomic Results in Cancer in the SWOG 1400 (S1400) Clinical Trial Adult CIRB - Late Phase Emphasis
NWU2014-04-01 CLO-Northwestern University Statin Therapy to Reduce the Risk of Recurrent Pancreatitis Cancer Prevention and Control CIRB Available to Open
9930 ETCTN A Phase I Trial of MEDI-570 in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL) Follicular Variant and Angioimmunoblastic T-Cell Lymphoma (AITL) Adult CIRB - Early Phase Emphasis Available to Open
ADVL1412 COG A Phase 1/2 Study of Nivolumab (IND# 124729) in Children; Adolescents; and Young Adults with Recurrent or Refractory Solid Tumors as a Single Agent and in Combination with Ipilimumab Pediatric CIRB Available to Open
EAA172 ECOG-ACRIN Phase 1/2 Study of Daratumumab, Bortezomib, Dexamethasone with or without Venetoclax in Relapsed/Refractory Multiple Myeloma with Assessment for t(11;14) Status Adult CIRB - Late Phase Emphasis Available to Open
S0931 SWOG EVEREST: EVErolimus for Renal Cancer Ensuing Surgical Therapy; A Phase III Study Adult CIRB - Late Phase Emphasis Available to Open
EA3132 ECOG-ACRIN Phase II Randomized Trial of Adjuvant Radiotherapy with or Without Cisplatin for p53 Mutated; Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) Adult CIRB - Late Phase Emphasis Available to Open
AAML1031 COG A Phase III Randomized Trial for Patients with de novo AML using Bortezomib and Sorafenib (IND#114480; NSC# 681239; NSC# 724772) for Patients with High Allelic Ratio FLT3/ITD Pediatric CIRB Available to Open
10106 ETCTN A phase I and randomized phase II study of KW-0761 (Mogamulizumab) and MK-3475 (Pembrolizumab) in relapsed and refractory lymphomas Adult CIRB - Early Phase Emphasis Available to Open
RTOG-0436 RTOG A Phase III Trial Evaluating the Addition of Cetuximab to Paclitaxel; Cisplatin; and Radiation for Patients with Esophageal Cancer who are Treated without Surgery Adult CIRB - Late Phase Emphasis Available to Open
Displaying 1 - 10 of 730